Drug Database
Back to search

France· FR:63824615

LOGIRENE, comprimé sécable

A medicinal product containing furosémide + amiloride (chlorhydrate d') hydraté, registered in France by LABORATOIRE XO, on the national reimbursement list.

Reimbursed in France (Assurance maladie)

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedLOGIRENE, comprimé sécableATC—REGISTER NO.FR:63824615PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about furosémide + amiloride (chlorhydrate d') hydratéAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
FUROSÉMIDE + AMILORIDE (CHLORHYDRATE D') HYDRATÉ
Manufacturer
LABORATOIRE XO
Country
France (FR)
ATC code
—
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400932975785
    plaquette(s) thermoformée(s) PVC-Aluminium de 30 comprimé(s)
    EUR 5.15

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Furosémide + amiloride (chlorhydrate d') hydraté in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All furosémide + amiloride (chlorhydrate d') hydraté products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • Belgium · Frusamil
  • Cyprus · Frumil
  • United Kingdom (Northern Ireland) · Co-Amilofruse, Co-Amilofruse Wockhardt Uk
  • Greece · Frumil
  • Ireland · Frumil
  • Luxembourg · Frusamil

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/aa9a3db9-5c24-45ca-9ab0-4a508eb06c35
GET /v1/drugs/aa9a3db9-5c24-45ca-9ab0-4a508eb06c35?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "63824615",
  "date_amm": "1987-07-10",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "FUROSÉMIDE + AMILORIDE (CHLORHYDRATE D') HYDRATÉ",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé sécable",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about furosémide + amiloride (chlorhydrate d') hydraté.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console